Skip to main content
17 January 2021
Last updated:
Saturday 16 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
    • Research Directory
    • Organisations
    • Interviewees
    • Terms
    • Topics
  • Contact Us

Research Directory

  • Targeting new medicines at Roche

    Sunday 12 January 2014
    Interviewee/Contributor
    Max Hasmann
    Organisation
    Roche Group
    Antibody Drug Conjugates ADCs
    Cancer (Oncology)
    Personalised medicine
    Breast cancer
    • Read more about Targeting new medicines at Roche

Organisations

  • Boston Consulting Group
  • Alliance for Regenerative Medicine
  • Aduro Biotech Inc
  • AstraZeneca
  • NDA Advisory Services Ltd
  • Themis Bioscience GmbH
  • London Business School
  • Auspherix Ltd
  • ThromboGenics NV
  • National Institute for Biological Standards and Control

Interviewees and Contributers

  • Stéphane Boissel
  • Roel Bellens
  • Richard Zimmerman
  • Donald Light
  • Peter Charlish
  • Yasmin de Faria Krim
  • Roch Doliveux
  • Dolores Schendel
  • Kevin Marsh
  • Stephen Megit

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021
Sam Herbert becomes COO at Clinigen
Wednesday January 6 2021
Wolfgang Baiker becomes CEO at Adrenomed
Wednesday January 6 2021
Alligator Bioscience appoints new CMO
Tuesday December 29 2020

© 2021 Evernow Publishing Ltd. Powered by Drupal.